Latest filing published 28 Aug 2026 for Precigen, INC., €1.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey B. Kindler (senior executive) discloses dealings in 4 companies, chiefly Precigen, Inc., PERRIGO Co plc and PPD, Inc. Over a trading history stretching from 7 May 2021 to 26 August 2026, the count stands at 22 filings.
Sales make up the whole of the open-market record (6 sales, €2.8M). Other entries cover 6 share grants and 9 option exercises. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 28 August 2026, reports an open-market sale of €1.2M in Precigen, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations